503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-22.89%
Negative net income growth while ORCL stands at 13.91%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
12.98%
D&A growth well above ORCL's 4.14%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-1057.14%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
2.78%
Less SBC growth vs. ORCL's 17.33%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
86.98%
Well above ORCL's 80.48% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
175.85%
AR growth well above ORCL's 71.83%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-105.61%
Negative yoy inventory while ORCL is 27.78%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-164.77%
Both negative yoy AP, with ORCL at -169.12%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
1.75%
Lower 'other working capital' growth vs. ORCL's 83.80%. David Dodd would see fewer unexpected short-term demands on cash.
-0.64%
Negative yoy while ORCL is 4066.67%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
63.66%
Operating cash flow growth below 50% of ORCL's 139.84%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-50.40%
Both yoy lines negative, with ORCL at -10.08%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
99.03%
Some acquisitions while ORCL is negative at -892.11%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-138.39%
Negative yoy purchasing while ORCL stands at 5.78%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-12.33%
We reduce yoy sales while ORCL is 5.96%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
223.63%
Growth of 223.63% while ORCL is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-119.85%
Both yoy lines negative, with ORCL at -256.91%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
65.30%
We slightly raise equity while ORCL is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
1.82%
We have some buyback growth while ORCL is negative at -66.23%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.